Crinetics Pharmaceuticals (NASDAQ:CRNX) Earns Overweight Rating from Cantor Fitzgerald
Cantor Fitzgerald restated their overweight rating on shares of Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) in a research report sent to investors on Monday, Benzinga reports. The firm currently has a $50.00 price target on the stock. A number of other brokerages also recently issued reports on CRNX. Robert W. Baird upped their price target […]
More Stories
Margaret and Jack got separated after 3 Years of Marriage!
For everyone who is searching for the recent trendy news about the separation of Margaret Qualley and Jack Antonoff, here...
Mousetrap: K-drama: Release Date, Trailer, Cast Members, and More
If you love intense drama with lots of thriller and psychological tension, then I have some good news for you....
Dylan Jagger Lee and Paula Bruss are Married! Know the Wedding Venue and Other Details
Have you also heard the news about Pamela’s son getting married? Yes, the news is correct! Dylan Jagger Lee, the...
The Map of Longing: Release Date, Cast Members, Trailer, and Synopsis
Are you ready for an emotional and loving journey between two sisters? If you are a fan of a chaotic...
Netflix has announced the Release Date for Steps, a Cinderella Spin-Off
Mark your calendar! Netflix has brought an all-new anime film, Steps, for a 2026 release. The film flips the classic...
Avatar: The Last Airbender Season 3: Release Date, Trailer, and Cast Members
Everyone’s favourite animated series, Avatar: The Last Airbender, is coming back with more action-packed visuals to captivate its audience once...
